NEOG
Neogen Corporation
Price Chart
No historical data available
Latest Quote
$11.52
-0.14 (-1.20%)
Current Price
| Previous Close | $11.66 |
| Open | $11.59 |
| Day High | $11.62 |
| Day Low | $11.46 |
| Volume | 516,035 |
Stock Information
| Shares Outstanding | 218.11M |
| Total Debt | $812.60M |
| Cash Equivalents | $185.50M |
| Revenue | $870.40M |
| Net Income | $-7.90M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $2.51B |
| EPS (TTM) | $-0.04 |
| Exchange | NMS |
Recent Price History
No history data available. Data will be fetched automatically.
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
đ° Latest News
No news articles available at the moment. Check back later for updates on NEOG.
Period:
Loading...
Income Statement (Annual)
| Metric | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $461,900,000 | $473,300,000 | $460,300,000 | $416,492,000 |
| Cost Of Revenue | $461,900,000 | $473,300,000 | $460,300,000 | $416,492,000 |
| Total Revenue | $870,400,000 | $894,700,000 | $924,200,000 | $822,447,000 |
| Operating Revenue | $870,400,000 | $894,700,000 | $924,200,000 | $822,447,000 |
| Expenses | ||||
| Interest Expense | $57,600,000 | $68,500,000 | $67,000,000 | $55,961,000 |
| Total Expenses | $892,000,000 | $896,400,000 | $865,600,000 | $784,932,000 |
| Other Income Expense | $70,200,000 | $-1,062,900,000 | $-5,900,000 | $-6,762,000 |
| Other Non Operating Income Expenses | $-6,200,000 | $-3,600,000 | $-5,900,000 | $-6,762,000 |
| Net Non Operating Interest Income Expense | $-57,600,000 | $-68,500,000 | $-67,000,000 | $-52,795,000 |
| Interest Expense Non Operating | $57,600,000 | $68,500,000 | $67,000,000 | $55,961,000 |
| Operating Expense | $430,100,000 | $423,100,000 | $405,300,000 | $368,440,000 |
| Selling And Marketing Expense | $166,600,000 | $183,800,000 | $182,900,000 | $141,222,000 |
| General And Administrative Expense | $245,100,000 | $218,200,000 | $199,900,000 | $201,179,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-7,900,000 | $-1,092,000,000 | $-9,400,000 | $-22,870,000 |
| Net Interest Income | $-57,600,000 | $-68,500,000 | $-67,000,000 | $-52,795,000 |
| Normalized Income | $-74,962,222 | $-71,123,114 | $-9,400,000 | $-22,870,000 |
| Net Income From Continuing And Discontinued Operation | $-7,900,000 | $-1,092,000,000 | $-9,400,000 | $-22,870,000 |
| Total Operating Income As Reported | $-21,600,000 | $-1,061,000,000 | $58,600,000 | $37,515,000 |
| Net Income Common Stockholders | $-7,900,000 | $-1,092,000,000 | $-9,400,000 | $-22,870,000 |
| Net Income | $-7,900,000 | $-1,092,000,000 | $-9,400,000 | $-22,870,000 |
| Net Income Including Noncontrolling Interests | $-7,900,000 | $-1,092,000,000 | $-9,400,000 | $-22,870,000 |
| Net Income Continuous Operations | $-7,900,000 | $-1,092,000,000 | $-9,400,000 | $-22,870,000 |
| Pretax Income | $-9,000,000 | $-1,133,100,000 | $-14,300,000 | $-22,042,000 |
| Special Income Charges | $76,400,000 | $-1,059,300,000 | $0 | $0 |
| Operating Income | $-21,600,000 | $-1,700,000 | $58,600,000 | $37,515,000 |
| Gross Profit | $408,500,000 | $421,400,000 | $463,900,000 | $405,955,000 |
| Interest Income | - | $3,110,000 | $6,362,000 | $3,166,000 |
| Interest Income Non Operating | - | $3,110,000 | $6,362,000 | $3,166,000 |
| Per Share | ||||
| Diluted EPS | $-0.04 | $-5.03 | $-0.04 | $-0.12 |
| Basic EPS | $-0.04 | $-5.03 | $-0.04 | $-0.11 |
| Other | ||||
| Tax Effect Of Unusual Items | $9,337,778 | $-38,423,114 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $94,100,000 | $120,400,000 | $173,900,000 | $124,393,000 |
| Total Unusual Items | $76,400,000 | $-1,059,300,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $76,400,000 | $-1,059,300,000 | $0 | $0 |
| Reconciled Depreciation | $121,900,000 | $125,700,000 | $121,200,000 | $90,474,000 |
| EBITDA (Bullshit earnings) | $170,500,000 | $-938,900,000 | $173,900,000 | $124,393,000 |
| EBIT | $48,600,000 | $-1,064,600,000 | $52,700,000 | $33,919,000 |
| Diluted Average Shares | $217,500,000 | $217,044,498 | $216,614,407 | $216,245,501 |
| Basic Average Shares | $217,500,000 | $217,044,498 | $216,614,407 | $216,245,501 |
| Diluted NI Availto Com Stockholders | $-7,900,000 | $-1,092,000,000 | $-9,400,000 | $-22,870,000 |
| Tax Provision | $-1,100,000 | $-41,100,000 | $-4,900,000 | $828,000 |
| Gain On Sale Of Business | $76,400,000 | $0 | $0 | - |
| Impairment Of Capital Assets | $0 | $1,059,300,000 | $0 | $0 |
| Research And Development | $18,400,000 | $21,100,000 | $22,500,000 | $26,039,000 |
| Selling General And Administration | $411,700,000 | $402,000,000 | $382,800,000 | $342,401,000 |
| Other Gand A | $245,100,000 | $218,200,000 | $199,900,000 | $201,179,000 |
Fetched: 2026-08-11
Balance Sheet (Annual)
| Metric | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-272,300,000 | $-403,600,000 | $-503,143,000 | $-608,381,000 |
| Total Assets | $3,346,000,000 | $3,443,800,000 | $4,548,833,000 | $4,554,432,000 |
| Total Non Current Assets | $2,741,400,000 | $2,866,300,000 | $3,959,600,000 | $3,968,500,000 |
| Other Non Current Assets | $29,800,000 | $35,200,000 | $20,426,000 | $15,220,000 |
| Goodwill And Other Intangible Assets | $2,365,200,000 | $2,474,800,000 | $3,647,285,000 | $3,742,598,000 |
| Other Intangible Assets | $1,318,000,000 | $1,409,900,000 | $1,511,653,000 | $1,605,102,000 |
| Current Assets | $604,600,000 | $576,900,000 | $589,233,000 | $585,931,000 |
| Other Current Assets | $60,000,000 | $53,300,000 | $56,025,000 | $53,297,000 |
| Assets Held For Sale Current | $68,000,000 | $50,400,000 | $0 | - |
| Inventory | $144,300,000 | $190,800,000 | $189,267,000 | $133,812,000 |
| Receivables | $146,800,000 | $153,400,000 | $173,005,000 | $153,253,000 |
| Accounts Receivable | $146,800,000 | $153,400,000 | $173,005,000 | $153,253,000 |
| Allowance For Doubtful Accounts Receivable | $-4,000,000 | $-5,400,000 | $-4,140,000 | $-2,827,000 |
| Gross Accounts Receivable | $150,800,000 | $158,800,000 | $177,145,000 | $156,080,000 |
| Cash Cash Equivalents And Short Term Investments | $185,500,000 | $129,000,000 | $170,936,000 | $245,569,000 |
| Cash And Cash Equivalents | $185,500,000 | $129,000,000 | $170,611,000 | $163,240,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $608,200,000 | $765,100,000 | $720,227,000 | $722,199,000 |
| Total Debt | $793,700,000 | $894,100,000 | $890,838,000 | $885,439,000 |
| Long Term Debt And Capital Lease Obligation | $793,700,000 | $874,800,000 | $888,391,000 | $885,439,000 |
| Long Term Debt | $793,700,000 | $874,800,000 | $888,391,000 | $885,439,000 |
| Current Debt And Capital Lease Obligation | - | $19,300,000 | $2,447,000 | - |
| Current Debt | - | $19,300,000 | $2,447,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,253,100,000 | $1,372,600,000 | $1,404,691,000 | $1,420,215,000 |
| Total Non Current Liabilities Net Minority Interest | $1,094,900,000 | $1,198,600,000 | $1,250,368,000 | $1,274,743,000 |
| Other Non Current Liabilities | $43,600,000 | $42,900,000 | $35,259,000 | $35,877,000 |
| Non Current Deferred Liabilities | $257,600,000 | $280,900,000 | $326,718,000 | $353,427,000 |
| Non Current Deferred Taxes Liabilities | $257,600,000 | $280,900,000 | $326,718,000 | $353,427,000 |
| Current Liabilities | $158,200,000 | $174,000,000 | $154,323,000 | $145,472,000 |
| Other Current Liabilities | $30,500,000 | $38,700,000 | $22,800,000 | $20,934,000 |
| Current Deferred Liabilities | $3,600,000 | $5,600,000 | $4,632,000 | $4,616,000 |
| Payables And Accrued Expenses | $97,300,000 | $96,300,000 | $104,495,000 | $94,769,000 |
| Interest Payable | $11,000,000 | $11,100,000 | $10,985,000 | $11,149,000 |
| Payables | $86,300,000 | $85,200,000 | $93,510,000 | $83,620,000 |
| Total Tax Payable | $7,200,000 | $5,600,000 | $10,449,000 | $6,951,000 |
| Income Tax Payable | $7,200,000 | $5,600,000 | $10,449,000 | $6,951,000 |
| Accounts Payable | $79,100,000 | $79,600,000 | $83,061,000 | $76,669,000 |
| Equity | ||||
| Common Stock Equity | $2,092,900,000 | $2,071,200,000 | $3,144,142,000 | $3,134,217,000 |
| Total Equity Gross Minority Interest | $2,092,900,000 | $2,071,200,000 | $3,144,142,000 | $3,134,217,000 |
| Stockholders Equity | $2,092,900,000 | $2,071,200,000 | $3,144,142,000 | $3,134,217,000 |
| Gains Losses Not Affecting Retained Earnings | $-13,600,000 | $-28,900,000 | $-30,021,000 | $-33,251,000 |
| Other Equity Adjustments | $-13,600,000 | $-28,900,000 | $-30,021,000 | $-33,251,000 |
| Retained Earnings | $-544,300,000 | $-536,400,000 | $555,620,000 | $565,041,000 |
| Other | ||||
| Ordinary Shares Number | $217,700,000 | $217,044,498 | $216,614,407 | $216,245,501 |
| Share Issued | $217,700,000 | $217,044,498 | $216,614,407 | $216,245,501 |
| Tangible Book Value | $-272,300,000 | $-403,600,000 | $-503,143,000 | $-608,381,000 |
| Invested Capital | $2,886,600,000 | $2,965,300,000 | $4,034,980,000 | $4,019,656,000 |
| Working Capital | $446,400,000 | $402,900,000 | $434,910,000 | $440,459,000 |
| Capital Lease Obligations | $0 | - | $0 | $0 |
| Total Capitalization | $2,886,600,000 | $2,946,000,000 | $4,032,533,000 | $4,019,656,000 |
| Additional Paid In Capital | $2,616,000,000 | $2,601,800,000 | $2,583,885,000 | $2,567,828,000 |
| Capital Stock | $34,800,000 | $34,700,000 | $34,658,000 | $34,599,000 |
| Common Stock | $34,800,000 | $34,700,000 | $34,658,000 | $34,599,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | - | $0 | - |
| Current Deferred Revenue | $3,600,000 | $5,600,000 | $4,632,000 | $4,616,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $26,800,000 | $14,100,000 | $19,949,000 | $25,153,000 |
| Current Accrued Expenses | $11,000,000 | $11,100,000 | $10,985,000 | $11,149,000 |
| Goodwill | $1,047,200,000 | $1,064,900,000 | $2,135,632,000 | $2,137,496,000 |
| Net PPE | $346,400,000 | $356,300,000 | $291,889,000 | $210,682,000 |
| Accumulated Depreciation | $-150,600,000 | $-155,400,000 | $-140,288,000 | $-120,118,000 |
| Gross PPE | $497,000,000 | $511,700,000 | $432,177,000 | $330,800,000 |
| Construction In Progress | $69,800,000 | $186,200,000 | $113,968,000 | $52,237,000 |
| Other Properties | $16,600,000 | $17,200,000 | $14,785,000 | $11,933,000 |
| Machinery Furniture Equipment | $165,700,000 | $188,800,000 | $184,629,000 | $159,627,000 |
| Buildings And Improvements | $234,200,000 | $108,700,000 | $108,298,000 | $96,794,000 |
| Land And Improvements | $10,700,000 | $10,800,000 | $10,497,000 | $10,209,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-17,200,000 | $-16,500,000 | $-12,361,000 | $-6,270,000 |
| Finished Goods | $102,400,000 | $130,400,000 | $111,839,000 | $68,099,000 |
| Work In Process | $8,000,000 | $11,200,000 | $10,990,000 | $5,366,000 |
| Raw Materials | $51,100,000 | $65,700,000 | $78,799,000 | $66,617,000 |
| Other Short Term Investments | - | $0 | $325,000 | $82,329,000 |
| Current Capital Lease Obligation | - | - | $2,447,000 | $0 |
Fetched: 2026-08-11
Cash Flow Statement (Annual)
| Metric | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $31,900,000 | $-46,400,000 | $-76,100,000 | $-24,729,000 |
| Operating Activities | ||||
| Operating Cash Flow | $83,200,000 | $58,200,000 | $35,300,000 | $41,028,000 |
| Cash Flow From Continuing Operating Activities | $83,200,000 | $58,200,000 | $35,300,000 | $41,028,000 |
| Operating Gains Losses | $-74,800,000 | $1,900,000 | $1,100,000 | $-486,000 |
| Investing Activities | ||||
| Capital Expenditure | $-51,300,000 | $-104,600,000 | $-111,400,000 | $-65,757,000 |
| Investing Cash Flow | $70,500,000 | $-99,200,000 | $-29,300,000 | $201,039,000 |
| Cash Flow From Continuing Investing Activities | $70,500,000 | $-99,200,000 | $-29,300,000 | $201,039,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-99,400,000 | $-1,600,000 | $1,900,000 | $-118,081,000 |
| Cash Flow From Continuing Financing Activities | $-99,400,000 | $-1,600,000 | $1,900,000 | $-118,081,000 |
| Net Other Financing Charges | $-900,000 | $-3,500,000 | $-100,000 | $-19,276,000 |
| Repurchase Of Capital Stock | - | - | - | - |
| Net Common Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-100,100,000 | $-550,300,000 | $-400,000 | $-100,000,000 |
| Issuance Of Debt | $0 | $550,000,000 | $0 | $0 |
| Interest Paid Supplemental Data | $58,300,000 | $68,100,000 | $73,200,000 | $42,616,000 |
| Income Tax Paid Supplemental Data | $17,700,000 | $26,500,000 | $22,300,000 | $15,473,000 |
| End Cash Position | $185,500,000 | $129,000,000 | $170,600,000 | $163,240,000 |
| Beginning Cash Position | $129,000,000 | $170,600,000 | $163,200,000 | $44,473,000 |
| Effect Of Exchange Rate Changes | $2,200,000 | $1,000,000 | $-500,000 | $-5,219,000 |
| Changes In Cash | $54,300,000 | $-42,600,000 | $7,900,000 | $123,986,000 |
| Proceeds From Stock Option Exercised | $1,600,000 | $2,200,000 | $2,400,000 | $1,195,000 |
| Net Issuance Payments Of Debt | $-100,100,000 | $-300,000 | $-400,000 | $-100,000,000 |
| Net Long Term Debt Issuance | $-100,100,000 | $-300,000 | $-400,000 | $-100,000,000 |
| Long Term Debt Payments | $-100,100,000 | $-550,300,000 | $-400,000 | $-100,000,000 |
| Long Term Debt Issuance | $0 | $550,000,000 | $0 | $0 |
| Net Investment Purchase And Sale | $0 | $300,000 | $82,000,000 | $254,249,000 |
| Sale Of Investment | $0 | $300,000 | $82,000,000 | $266,772,000 |
| Net Business Purchase And Sale | $121,700,000 | $0 | $0 | $11,721,000 |
| Sale Of Business | $121,700,000 | $0 | $0 | $11,721,000 |
| Net PPE Purchase And Sale | $-51,200,000 | $-99,500,000 | $-111,300,000 | $-64,931,000 |
| Sale Of PPE | $100,000 | $5,100,000 | $100,000 | $826,000 |
| Purchase Of PPE | $-51,300,000 | $-104,600,000 | $-111,400,000 | $-65,757,000 |
| Change In Working Capital | $52,100,000 | $-6,000,000 | $-72,700,000 | $-24,197,000 |
| Change In Other Working Capital | $-6,000,000 | $400,000 | $-21,600,000 | $154,000 |
| Change In Payables And Accrued Expense | $19,800,000 | $-400,000 | $13,800,000 | $22,694,000 |
| Change In Payable | $19,800,000 | $-400,000 | $13,800,000 | $18,642,000 |
| Change In Account Payable | $19,800,000 | $-400,000 | $13,800,000 | $18,642,000 |
| Change In Prepaid Assets | $-6,700,000 | $-1,500,000 | $11,100,000 | $-3,121,000 |
| Change In Inventory | $38,200,000 | $-16,100,000 | $-55,900,000 | $9,955,000 |
| Change In Receivables | $6,800,000 | $11,600,000 | $-20,100,000 | $-53,879,000 |
| Changes In Account Receivables | $6,800,000 | $11,600,000 | $-20,100,000 | $-53,879,000 |
| Other Non Cash Items | $2,800,000 | $400,000 | $8,100,000 | $7,160,000 |
| Stock Based Compensation | $13,400,000 | $17,300,000 | $13,800,000 | $10,177,000 |
| Asset Impairment Charge | $0 | $1,068,700,000 | $600,000 | $0 |
| Deferred Tax | $-24,300,000 | $-57,800,000 | $-27,400,000 | $-19,230,000 |
| Deferred Income Tax | $-24,300,000 | $-57,800,000 | $-27,400,000 | $-19,230,000 |
| Depreciation Amortization Depletion | $121,900,000 | $125,700,000 | $121,200,000 | $90,474,000 |
| Depreciation And Amortization | $121,900,000 | $125,700,000 | $121,200,000 | $90,474,000 |
| Depreciation | $121,900,000 | $125,700,000 | $121,200,000 | $90,474,000 |
| Gain Loss On Sale Of PPE | $1,200,000 | $0 | $1,100,000 | $-486,000 |
| Gain Loss On Sale Of Business | $-76,400,000 | $0 | $0 | - |
| Net Income From Continuing Operations | $-7,900,000 | $-1,092,000,000 | $-9,400,000 | $-22,870,000 |
| Purchase Of Investment | - | $0 | $0 | $-12,523,000 |
| Change In Accrued Expense | - | $93,000 | $-164,000 | $4,052,000 |
| Change In Interest Payable | - | $93,000 | $-164,000 | $4,052,000 |
| Purchase Of Business | - | - | - | - |
| Common Stock Payments | - | - | - | - |
Fetched: 2026-08-11